Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Alexander Ruebben , Juergen Boeing , Norbert Weiss Added: 3 years ago
The Elutax© is a rapid exchange percutaneous transluminal coronary angioplasty (PTCA) catheter. There are two versions: one for standard-size coronary and small peripheral vessels (Elutax 2nd Generation) and one for small coronary vessels (Elutax SV). The Aachen Resonance® Elutax drug-eluting balloon family was developed especially for coronary arteries and venous bypass as well as for small… View more

Imaging & Diagnostics

Intervention
Author(s): Alexander Ruebben , Juergen Boeing , Norbert Weiss Added: 3 years ago
More drug-eluting balloons are entering the market. However, it is difficult for the user to understand the differences between these devices. This article aims to increase understanding of these devices, from the point of view of the manufacturer and for benefit of the user. The differences of the balloon coating can be found: in the loading dose; in the excipient; and in the way the… View more

MI/ACS

Intervention
Author(s): Ferry van der Linde Added: 3 years ago
Recently, a novel type of interventional device has become available on the market: the drug-eluting balloon (DEB). The established performance of the percutaneous transluminal coronary angioplasty (PTCA) balloon catheter has been combined with the proven efficacy of antiproliferative drugs. The usefulness of DEBs has been established,1–6 especially for treating in-stent restenosis (ISR), when… View more

Prevention & Chronic Conditions
Job title: Consultant of vascular and endovascular surgery
Dr Konstantinos Stavroulakis is a Consultant Vascular and Endovascular Surgeon at St. Franziskus Hospital, Münster, Germany. He trained at the University of Crete Medical School until 2009. He moved to Germany in 2012 and became a Trainee of Surgery and Vascular Surgery at the Paracelsus Clinic Marl, Germany. He achieved his Postgraduate (Dr.med) qualification in March 2016 from the Westphälische… View more
Job title: Consultant Interventional Radiologist
Dr Jason Wilkins trained in medicine at St. Edmund Hall Oxford and was appointed as a Consultant Radiologist at King’s College Hospital in 2002. He is currently clinical lead for interventional radiology and musculoskeletal imaging. His specialist interests in intervention and musculoskeletal imaging include endovascular therapy, tumour ablation, venous and dialysis access and urolological… View more
Drug-eluting Balloons in CAD – Current and Future Perspectives
Author(s): Anouar Belkacemi , Pierfrancesco Agostoni , Michiel Voskuil , et al Added: 3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Drug-coated Balloon-only Angioplasty
Author(s): Upul Wickramarachchi , Simon Eccleshall Added: 3 years ago
Percutaneous coronary interventional techniques and devices have evolved enormously since Gruntzig performed his first coronary angioplasty in 1977. 1 It is now the norm to treat patients with both acute coronary syndrome and stable coronary artery disease with drug-eluting stents. We intend to review the evidence and discuss potential benefits of drug-coated balloon-only angioplasty. These… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 5 months ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
EuroPCR 22: SCB with Micro-Reservoir Technology in Coronary Lesions
Author(s): Praveen Chandra Added: 1 year ago
In this short interview, Dr Praveen Chandra (Medanta - The Medicity, IN) shares key findings from the study that looked at the sirolimus-coated balloon with micro-reservoir technology in coronary lesions. The study investigated the SELUTION SLR drug-eluting balloon (MedAlliance) for coronary and peripheral indications. Discussion Points: 1. Study Rationale 2. Micro-reservoir Technology 3. Study… View more

Intervention
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
Author(s): Raban Jeger , Thomas Nestelberger Added: 3 years ago
Coronary artery disease (CAD) remains a major cause of morbidity and mortality despite major improvements in primary and secondary prevention strategies. Percutaneous coronary intervention (PCI) or surgical revascularisation may be indicated in many patients with acute or stable CAD.1 Since the first coronary intervention using catheter mounted balloons, percutaneous treatment of CAD has evolved… View more

Intervention